| Life After a Breast, Prostate or Colorectal Cancer: The Experience of Swiss Survivors | Cancer care research online | | | 2025 | 7 | 72 |
|
| Domains and categories of needs in long-term follow-up of adult cancer survivors : a scoping review of systematic reviews | Healthcare | | | 2024 | 99 | 290 |
|
| Experiences and Needs of Swiss Cancer Survivors in the Domains of Health-Related Information and the Healthcare System | Cancers | | | 2024 | 98 | 305 |
|
| Brain Metastases from Genito-Urinary Cancers in the Canton of Geneva (Switzerland) : Study of Incidence, Management and Outcomes | Cancers | | | 2024 | 94 | 541 |
|
| Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study | Cancer | | | 2024 | 167 | 169 |
|
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | | | 2024 | 108 | 93 |
|
| Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon : a retrospective study | Swiss medical weekly | | | 2023 | 66 | 58 |
|
| Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics | International journal of cancer | | | 2023 | 516 | 106 |
|
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | | 2023 | 328 | 234 |
|
| Cancer vaccines | Cancer cell | | | 2022 | 316 | 238 |
|
| Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | | | 2022 | 261 | 270 |
|
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised | Nature reviews. Neuroscience | | | 2022 | 172 | 1 |
|
| Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer | iScience | | | 2022 | 245 | 199 |
|
| Hyaline cartilage microtissues engineered from adult dedifferentiated chondrocytes: safety and role of WNT signaling | Stem cells translational medicine | | | 2022 | 456 | 217 |
|
| Linking unfolded protein response to ovarian cancer cell fusion | BMC cancer | | | 2022 | 293 | 304 |
|
| The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | | | 2022 | 189 | 206 |
|
| Modeling poliovirus infection using human engineered neural tissue enriched with motor neuron derived from embryonic stem cells | Frontiers in Cell and Developmental Biology | | | 2021 | 374 | 182 |
|
| SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical Cohort | Microorganisms | | | 2021 | 205 | 150 |
|
| Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy | Science Immunology | | | 2021 | 474 | 1,019 |
|
| Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread | Neurology Genetics | | | 2021 | 340 | 151 |
|
| Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer | Cancer Cell | | | 2021 | 298 | 425 |
|
| Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | | | 2021 | 266 | 352 |
|
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | | | 2021 | 349 | 232 |
|
| Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm? | Cancer treatment reviews | | | 2021 | 77 | 249 |
|
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | | | 2020 | 445 | 195 |
|
| An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metformin | Biology (Basel)[2079-7737] | | | 2020 | 489 | 342 |
|
| Journée du cancer : mobiliser autour de la prévention | Revue médicale suisse | | | 2020 | 242 | 167 |
|
| Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma | Transplantation | | | 2020 | 351 | 470 |
|
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | | | 2020 | 463 | 337 |
|
| Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients | Frontiers in Oncology | | | 2020 | 357 | 190 |
|
| Oncologie : naviguer la pandémie de COVID-19 et garder le cap | Revue médicale suisse | | | 2020 | 265 | 176 |
|
| Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool | Health Science Reports | | | 2020 | 217 | 284 |
|
| Une période de craintes et de défis : vers un monde meilleur ? | Revue médicale suisse | | | 2020 | 211 | 0 |
|
| Stratégies de vaccination thérapeutique dans le glioblastome | Medecine Sciences | | | 2020 | 220 | 448 |
|
| Resources-stratified guidelines for classical hodgkin lymphoma | International Journal of Environmental Research and Public Health | | | 2020 | 418 | 574 |
|
| Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers | | | 2020 | 348 | 356 |
|
| Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma | Molecular and Cellular Proteomics | | | 2019 | 440 | 2 |
|
| De sérieuses préoccupations qui ne cachent pas nos espoirs | Revue médicale suisse | | | 2019 | 298 | 158 |
|
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | | | 2019 | 857 | 844 |
|
| Current strategies for vaccination in glioblastoma | Current Opinion in Oncology | | | 2019 | 405 | 5 |
|
| Peptides as cancer vaccines | Current Opinion in Pharmacology | | | 2019 | 428 | 4 |
|
| Actively personalized vaccination trial for newly diagnosed glioblastoma | Nature | | | 2019 | 572 | 12 |
|
| Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patients | Cancers | | | 2019 | 375 | 247 |
|
| Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma | Scientific Reports | | | 2019 | 280 | 828 |
|
| Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point | Journal of Clinical Oncology | | | 2018 | 507 | 1 |
|
| CAR T-Cell Therapies in Glioblastoma: A First Look | Clinical Cancer Research | | | 2018 | 600 | 2 |
|
| Onco-sexologie : un regard au cœur des patients | Revue médicale suisse | | | 2018 | 301 | 202 |
|
| De vrais espoirs et de sérieuses préoccupations | Revue médicale suisse | | | 2018 | 340 | 2 |
|
| Learning from the past to design better trials in second-line treatment for mesothelioma patients | Ecancermedicalscience | | | 2018 | 365 | 154 |
|
| Médecine sexuelle et cancers : une main tendue vers l'humain | Revue médicale suisse | | | 2018 | 376 | 234 |
|
| Diagnosis and treatment of follicular lymphoma: an update | Swiss Medical Weekly | | | 2018 | 608 | 668 |
|
| Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors | The Journal of Pathology | | | 2018 | 896 | 6 |
|
| [Retracted] Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma | Molecular and Cellular Proteomics | | | 2018 | 447 | 16 |
|
| Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | | | 2018 | 437 | 1 |
|
| Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists | Canadian Journal of Cardiology | | | 2018 | 537 | 2 |
|
| « Docteur, je jeûne lors de la chimiothérapie » : illusion ou nouvelle réalité clinique ? | Revue médicale suisse | | | 2018 | 643 | 933 |
|
| Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland | Swiss Medical Weekly | | | 2018 | 629 | 293 |
|
| Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma | OncoImmunology | | | 2018 | 671 | 433 |
|
| Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy | Nutrition and Cancer | | | 2018 | 489 | 543 |
|
| Prise en charge de la sexualité chez les patients oncologiques: Un projet de recherche au sein des Hôpitaux universitaires de Genève | Revue médicale suisse | | | 2018 | 413 | 334 |
|
| BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma | Neurology | | | 2017 | 552 | 260 |
|
| First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies | OncoImmunology | | | 2017 | 660 | 9 |
|
| A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells | Oncotarget | | | 2017 | 540 | 263 |
|
| Les cancers s'envolent, les progrès suivent | Tribune de Geneve | | | 2017 | 393 | 85 |
|
| Immunothérapie des gliomes : illusion ou espoir ? | Bulletin du cancer | | | 2017 | 431 | 0 |
|
| Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer | Digestive and Liver Disease | | | 2017 | 533 | 0 |
|
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial | The Lancet Oncology | | | 2017 | 432 | 1 |
|
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports | | | 2017 | 602 | 4 |
|
| ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells | EMBO Journal | | | 2017 | 627 | 10 |
|
| 8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016 | Drug Metabolism and Personalized Therapy | | | 2017 | 583 | 3 |
|
| Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients | British Journal of Haematology | | | 2017 | 465 | 0 |
|
| Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma | Cancer Cell | | | 2017 | 520 | 5 |
|
| L'accès à l'innovation | Revue médicale suisse | | | 2017 | 349 | 0 |
|
| Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? | Frontiers in Oncology | | | 2016 | 540 | 478 |
|
| Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness | Biomaterials | | | 2016 | 569 | 5 |
|
| Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes | Journal of neuro-oncology | | | 2016 | 530 | 690 |
|
| Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis | Cancer medicine | | | 2016 | 587 | 261 |
|
| Cell-penetrating peptides-the Swiss Army knife of cancer vaccines | Oncoimmunology | | | 2016 | 656 | 376 |
|
| Progrès dans l'immunothérapie des tumeurs cérébrales : difficultés et perspectives | Revue médicale suisse | | | 2016 | 355 | 2 |
|
| Medulloblastoma in children and adults: one distinct disease entity? | Bulletin suisse du cancer | | | 2016 | 511 | 71 |
|
| Hypoxia and antitumor CD8(+) T cells: An incompatible alliance? | OncoImmunology | | | 2016 | 496 | 411 |
|
| Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing | PloS one | | | 2016 | 673 | 710 |
|
| Ipilimumab-related hypophysitis may precede severe CNS immune attack | Annals of Oncology | | | 2016 | 465 | 0 |
|
| Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants | Molecular therapy | | | 2016 | 686 | 406 |
|
| Chimiothérapie de maintenance : futile ou utile ? | Revue médicale suisse | | | 2015 | 490 | 239 |
|
| Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit | Supportive care in cancer | | | 2015 | 691 | 1 |
|
| Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells | European Journal of Immunology | | | 2015 | 557 | 7 |
|
| Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review | CNS oncology | | | 2015 | 514 | 0 |
|
| Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity | Cancer research | | | 2015 | 648 | 10 |
|
| La société face au cancer : prises de conscience et initiatives citoyennes | Revue médicale suisse | | | 2015 | 387 | 94 |
|
| Lymphome cérébral : une présentation classique ? | Revue médicale suisse | | | 2015 | 402 | 617 |
|
| Immunotherapy of Brain Tumors | Progress in tumor research | | | 2015 | 591 | 0 |
|
| Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome | Annals of oncology | | | 2015 | 495 | 233 |
|
| Création du Centre du cancer de la prostate des HUG | Revue médicale suisse | | | 2014 | 764 | 2 |
|
| Immunotherapy for glioma: from illusion to realistic prospects? | American Society of Clinical Oncology educational book | | | 2014 | 1,282 | 672 |
|
| Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma | British journal of cancer | | | 2014 | 673 | 238 |
|
| Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response | International journal of cancer | | | 2014 | 759 | 509 |
|
| Extrachromosomal driver mutations in glioblastoma and low-grade glioma | Nature communications | | | 2014 | 775 | 274 |
|
| Fine-needle aspiration biopsy for the diagnosis of metastatic type B thymoma to lymph nodes: A case report | Diagnostic cytopathology | | | 2014 | 627 | 0 |
|
| Injecting hope into brain cancer treatment: is immunotherapy the way forward? | CNS Oncology | | | 2014 | 408 | 0 |
|
| Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) | European urology | | | 2013 | 615 | 0 |
|
| Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients | Clinical & developmental immunology | | | 2013 | 652 | 616 |
|
| Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) | Revue médicale suisse | | | 2013 | 461 | 0 |
|
| Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours | PloS one | | | 2013 | 743 | 341 |
|
| The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma | Biomaterials | | | 2013 | 745 | 6 |
|
| Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy | Journal of neuro-oncology | | | 2013 | 699 | 0 |
|
| Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies | Immunotherapy | | | 2013 | 551 | 0 |
|
| Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival | Nature medicine | | | 2012 | 590 | 2 |
|
| MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status | Acta neuropathologica | | | 2012 | 617 | 1,138 |
|
| Plasmablastic lymphoma clinically presenting in the urinary tract | Annals of diagnostic pathology | | | 2012 | 673 | 0 |
|
| A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma | Haematologica | | | 2012 | 645 | 495 |
|
| Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy | Brain | | | 2012 | 717 | 1,702 |
|
| Complete remission with tyrosine kinase inhibitors in renal cell carcinoma | Journal of clinical oncology | | | 2012 | 769 | 867 |
|
| Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review | Case reports in oncological medicine | | | 2012 | 645 | 390 |
|
| Takotsubo syndrome secondary to adrenal adenocarcinoma: cortisol as a possible culprit | American journal of respiratory and critical care medicine | | | 2012 | 669 | 5 |
|
| A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | | | 2012 | 699 | 0 |
|
| Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis | Case reports in oncology | | | 2011 | 659 | 0 |
|
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | | 2011 | 1,058 | 683 |
|
| Soin nutritionnel intégré au soin oncologique : un besoin d'optimisation | Revue médicale suisse | | | 2011 | 994 | 881 |
|
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | | 2011 | 886 | 8 |
|
| Prevention of CNS relapse in diffuse large B-cell lymphoma | Lancet oncology | | | 2011 | 575 | 0 |
|
| Recurrent Syncope due to Esophageal Squamous Cell Carcinoma | Case reports in oncology | | | 2011 | 701 | 337 |
|
| Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report | Journal of medical case reports | | | 2011 | 627 | 183 |
|
| Oncology ESAB 2011 | | | | 2011 | 689 | 10 |
|
| Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma | GLIA | | | 2010 | 691 | 0 |
|
| [Retracted] Marker-independent identification of glioma-initiating cells | Nature methods | | | 2010 | 548 | 0 |
|
| Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98 | Journal of clinical oncology | | | 2010 | 560 | 0 |
|
| Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development | Cancer research | | | 2010 | 627 | 3 |
|
| T-cell immunotherapy for malignant glioma: toward a combined approach | Current opinion in oncology | | | 2010 | 670 | 2 |
|
| Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma | Journal of clinical oncology | | | 2010 | 632 | 0 |
|
| Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | | | 2009 | 673 | 0 |
|
| Limits of CD133 as a marker of glioma self-renewing cells | International journal of cancer | | | 2009 | 651 | 0 |
|
| Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant | Journal of immunotherapy | | | 2009 | 624 | 0 |
|
| Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital | British journal of cancer | | | 2009 | 712 | 0 |
|
| Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error? | Blood | | | 2009 | 555 | 1 |
|
| Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva) | Dermatology | | | 2008 | 560 | 0 |
|
| Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma | Journal of clinical oncology | | | 2008 | 701 | 0 |
|
| Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d'une étude multicentrique de l'Anocef | Revue neurologique | | | 2008 | 696 | 0 |
|
| Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome | Annals of oncology | | | 2008 | 597 | 0 |
|
| Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenance | Supportive care in cancer | | | 2008 | 655 | 324 |
|
| Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes | GLIA | | | 2008 | 667 | 11 |
|
| Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers | Annals of oncology | | | 2008 | 547 | 0 |
|
| Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system | World journal of surgical oncology | | | 2008 | 1,190 | 601 |
|
| Bortezomib-induced skin eruption | Dermatology | | | 2008 | 611 | 0 |
|
| Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas | Journal of pathology | | | 2006 | 655 | 0 |
|
| Cytomegalovirus colitis--a severe complication after standard chemotherapy | Acta oncologica | | | 2002 | 636 | 0 |
|
